Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.

The West Blog

Latest Post

February 20, 2019

Particles in Intravitreal Injections - Part I

Neovascular diseases of the eye are often chronic conditions treated with repeated intravitreal anti-VEGF injections. Although anti-VEGF therapies are preventing blindness, there are unique risks to intravitreal drug delivery that are exacerbated by the injection frequency. In particular, there is clinical evidence to suggest that some complications of these injections, though rare, might be tied to injection of particulate matter such as silicone oil, protein aggregates and foreign particulates.<sup>1,2</sup>
Susan Dounce

Susan Dounce, PhD

Principal SME, Pre-filled Syringes


Search the Blog





  • Previous Posts
    The ecommerce site on a desktop computer screen

    February 13, 2019

    Introducing West’s Online Store

    Carol Mooney

    Carol Mooney

    Director, Strategic Marketing, Biologics

    PFS Syringe Systems

    February 01, 2019

    Challenges in Drug Containment and Delivery: How to Qualify Prefillable Solutions

    Royce Brockett

    Royce Brockett

    Director, Product Management, Prefillable Systems

    Survey Responses

    January 25, 2019

    Industry Insight – Particles and Sterile Drug Products

    Verun Gupta

    Varun Gupta

    Supervisor, Particles, Analytical Labs NA

    CCI Testing

    December 11, 2018

    Container Closure Integrity at Low Temperatures

    West Pharma

    Amy Kim

    Specialist, Scientific Communications, TCS

    Load more